Associated Papers
Combinatorial screening for therapeutics in ATTRv amyloidosis identifies naphthoquinone analogues as TTR-selective amyloid disruptors.
Sasaki R et al.
Journal of Pharmacological Sciences, 2023
Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis.
Eldhagen P et al.
Journal of Internal Medicine, 2021
Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening.
Tsuda Y et al.
Scientific Reports, 2018
Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization.
Bonito-Oliva A et al.
Scientific Reports, 2017
The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies.
Leri M et al.
The Journal of Nutritional Biochemistry, 2016
Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis.
Ihse E et al.
Journal of Molecular Medicine (berlin, Germany), 2011
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.
Hurshman AR et al.
Biochemistry, 2004
Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation.
Sousa MM et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 2000
Select a paper to view details